Extended Data Fig. 6: Neurologic and developmental outcomes.
From: Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial
Clinical Global Impression severity and change from baseline are shown for each patient.
Extended Data Fig. 6: Neurologic and developmental outcomes. | Nature Medicine
